Allan R Brasier Selected Research

Interleukin-8 (Interleukin 8)

12/2005	Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.
4/2004	Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection.
6/2003	Regulation of airway epithelial cell NF-kappa B-dependent gene expression by protein kinase C delta.
6/2002	Interleukin-8 gene regulation in intestinal epithelial cells infected with rotavirus: role of viral-induced IkappaB kinase activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Allan R Brasier Research Topics

Disease

59	Inflammation (Inflammations) 05/2022 - 08/2002
28	Respiratory Syncytial Virus Infections 05/2022 - 07/2002
14	Infections 05/2022 - 06/2002
13	Asthma (Bronchial Asthma) 05/2022 - 06/2003
13	Airway Remodeling 05/2022 - 10/2016
13	Virus Diseases (Viral Diseases) 05/2022 - 06/2002
8	Fibrosis (Cirrhosis) 01/2020 - 12/2015
6	Lung Diseases (Lung Disease) 01/2022 - 06/2013
6	Neoplasms (Cancer) 11/2021 - 03/2004
5	Acute-Phase Reaction 02/2010 - 01/2003
5	Atherosclerosis 08/2008 - 08/2002
4	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019 - 05/2003
4	Aortic Dissection 06/2017 - 12/2009
4	Dengue (Dengue Fever) 03/2015 - 02/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2017
3	Insulin Resistance 01/2021 - 08/2008
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 10/2016
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016 - 07/2014
3	Burns 04/2015 - 06/2012
3	Severe Dengue 09/2013 - 02/2012
2	Hyperglycemia 01/2021 - 05/2006
2	Adenocarcinoma of Lung 10/2019 - 04/2015
2	Weight Loss (Weight Reduction) 01/2019 - 01/2018
2	Thrombosis (Thrombus) 01/2018 - 10/2017
2	Airway Obstruction (Choking) 01/2018 - 01/2017
2	Thoracic Aortic Aneurysm 01/2018 - 06/2017
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2018 - 10/2017
2	Hypoxia (Hypoxemia) 11/2017 - 02/2016
2	Abdominal Aortic Aneurysm 10/2017 - 08/2016
2	Leukemia 01/2015 - 11/2004
2	Vascular Remodeling 09/2013 - 09/2006
2	Sudden Infant Death (SID) 06/2013 - 06/2011

Drug/Important Bio-Agent (IBA)

43	Proteins (Proteins, Gene)FDA Link 05/2022 - 06/2002
32	CytokinesIBA 01/2022 - 06/2002
19	Transcription Factors (Transcription Factor)IBA 11/2021 - 01/2003
18	NF-kappa B (NF-kB)IBA 09/2016 - 06/2002
13	Interleukin-6 (Interleukin 6)IBA 08/2016 - 08/2002
12	ChemokinesIBA 01/2022 - 06/2002
11	InterferonsIBA 01/2017 - 01/2004
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2002
7	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 01/2004
7	Angiotensin IIIBA 10/2017 - 09/2006
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2017 - 07/2002
6	AllergensIBA 04/2022 - 01/2019
6	Phosphotransferases (Kinase)IBA 01/2021 - 08/2002
5	ChromatinIBA 01/2021 - 02/2010
5	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2002
5	Messenger RNA (mRNA)IBA 01/2021 - 07/2005
5	CollagenIBA 01/2019 - 09/2013
5	Peptides (Polypeptides)IBA 11/2017 - 03/2004
5	Antiviral Agents (Antivirals)IBA 06/2017 - 05/2003
5	Small Interfering RNA (siRNA)IBA 01/2016 - 02/2007
4	EnzymesIBA 05/2022 - 11/2015
4	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 03/2004
4	Biological ProductsIBA 01/2020 - 08/2002
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 03/2015
4	VaccinesIBA 11/2018 - 01/2012
4	IsotopesIBA 11/2017 - 06/2011
4	AntioxidantsIBA 11/2015 - 01/2004
4	I-kappa B KinaseIBA 09/2006 - 06/2002
4	Chemokine CCL5IBA 02/2006 - 08/2002
4	Interleukin-8 (Interleukin 8)IBA 12/2005 - 06/2002
3	Pharmaceutical PreparationsIBA 05/2022 - 01/2020
3	Protein Isoforms (Isoforms)IBA 12/2021 - 09/2010
3	AntibodiesIBA 11/2021 - 02/2016
3	Poly I-CIBA 01/2019 - 01/2017
3	ZL0454IBA 01/2019 - 01/2019
3	Histones (Histone)IBA 01/2018 - 01/2017
3	ProteomeIBA 11/2017 - 01/2016
3	Interferon Type IIBA 01/2014 - 01/2012
3	Interleukin-10 (Interleukin 10)IBA 09/2013 - 03/2004
3	ElementsIBA 02/2007 - 01/2004
3	InterleukinsIBA 09/2006 - 06/2002
2	Lipoproteins (Lipoprotein)IBA 05/2022 - 09/2004
2	Lysine (L-Lysine)FDA Link 11/2021 - 01/2017
2	RNA Polymerase II (RNA Polymerase B)IBA 01/2021 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2020
2	HexosaminesIBA 01/2021 - 01/2021
2	X-Box Binding Protein 1IBA 01/2021 - 01/2021
2	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2019 - 01/2018
2	AntigensIBA 01/2019 - 12/2017
2	Complement System Proteins (Complement)IBA 01/2019 - 05/2003
2	HMGB1 Protein (HMG1)IBA 11/2018 - 11/2016
2	Nuclear Proteins (Protein, Nuclear)IBA 11/2018 - 11/2016
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2018 - 06/2013
2	Toll-Like Receptor 3IBA 01/2018 - 01/2017
2	Thromboplastin (Tissue Factor)IBA 01/2018 - 10/2017
2	Antiphospholipid AntibodiesIBA 01/2018 - 10/2017
2	Immunoglobulin G (IgG)IBA 01/2018 - 10/2017
2	Cyclin-Dependent Kinase 9IBA 01/2017 - 06/2013
2	CXC ChemokinesIBA 01/2017 - 06/2002
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2016 - 06/2003
2	Toll-Like Receptor 4IBA 01/2016 - 01/2016
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2015 - 11/2009
2	Serine (L-Serine)FDA Link 03/2015 - 10/2009
2	Blood Proteins (Serum Proteins)IBA 01/2015 - 06/2012
2	Methacholine Chloride (Methacholine)FDA Link 08/2010 - 01/2008
2	Chemotactic FactorsIBA 05/2010 - 12/2009

Therapy/Procedure

10	Therapeutics 11/2021 - 09/2008
3	Drug Therapy (Chemotherapy) 11/2017 - 08/2004